Roivant Sciences Ltd. (ROIV) Earnings
NASDAQ·Healthcare·Biotechnology
$30.28
+1.88%
Mkt Cap $20.49B
Next Earnings
In 18 daysWed, Jul 1, 2026
EPS Estimate
-$0.29
2 analysts
Revenue Estimate
$3.82M
Last quarter: beat by +19.88% on EPS, -60.65% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$20.49B
P/E
—
Fwd P/E
—
P/S
2870.03
Rev TTM
—
EPS TTM
-$1.10